How to build your Quality Management System (QMS) without overcomplicating it, while meeting regulatory requirements?
This panel will explore how biotech companies can implement a QMS that is compliant, lean, fit-for-purpose, and sustainable—even with limited resources.
Bringing together experts who have navigated this journey from different perspectives, the discussion will focus on what truly matters: building a “right-sized” quality framework that meets regulatory expectations without unnecessary complexity.
Panelists will share real-world experiences on prioritizing and embedding quality quality into everyday operations.
Tuesday, May 5, 09:00 - 09:45, room Shanghai 1+2
| Name | Position | Institution |
|---|---|---|
| Ludovic Moulin | Managing Director | ObelysQ SA |
| Name | Position | Institution |
|---|---|---|
| Bettina Buddis | Head of Clinical Manufacturing | CDR-Life |
| Claudia Escher | Chief Operating Officer | Tolremo |
| Jan Krikava | Managing Director & Product Manager | Docuply UG |
| Arnaud Levain Chavanon | Managing Director | ObelysQ SA |
ObelysQ, founded in 2020 in Neuchâtel, is a leading global clinical quality consulting company, recognized for its expertise in GxP auditing, inspection readiness, quality management system development, training, and data privacy services.
With branches in the USA and in Poland, our experts combine deep regulatory knowledge with hands-on operational insight to deliver pragmatic, risk-based, and tailored solutions that strengthen compliance and clinical executions.
We proudly support biotechnology companies, pharmaceutical organizations, service providers, and clinical research sites worldwide in achieving sustainable quality excellence.
